electroCore (ECOR) Q2 FY26 earnings call

electroCore delivered strong Q2 FY26 results, marked by significant revenue growth and improved profitability, driven by strategic commercial reorganization and product diversification. The company raised its full-year revenue guidance and outlined a clear path to achieving positive adjusted EBITDA by Q3 2027, leveraging existing capital resources. Despite some operational headwinds, management expressed confidence in its multi-catalyst platform strategy in bioelectronic medicine.